france

Pierre Fabre Laboratories Announces Global Partnership with Know Your Lemons Foundation for Breast Cancer Awareness Month

Innovative Campaign Focuses on Early Detection and Empowering Education Throughout October CASTRES, France, Sept. 29, 2025 /PRNewswire/ -- Pierre Fabre Laboratories…

1 month ago

Net Rowdex: Why Net Rowdex 2025 Emerges as a Next-Gen AI Trading Platform for Investors Read France Report!

New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction to Net Rowdex Net Rowdex emerges in 2025 as…

1 month ago

MATHYS JAUBERT, DANIEL JUNCADELLA JOIN GENESIS MAGMA RACING WEC DRIVER LINEUP

Mathys Jaubert and Daniel Juncadella have been confirmed as part of Genesis Magma Racing’s driver lineup for the 2026 FIA…

2 months ago

GENESIS MAGMA RACING DRIVERS SHOW PACE AND DECISIVE STRATEGY TO SCORE THIRD WIN OF ELMS SEASON AT SILVERSTONE

Genesis Magma Racing Trajectory drivers Jamie Chadwick and Mathys Jaubert, along with Dani Juncadella, scored a third win of the…

2 months ago

Rising Star ASTRAUX Shines at IFA Berlin, Accelerates Expansion Across Key EU Markets

BERLIN, Sept. 8, 2025 /PRNewswire/ -- Dubai-based lifestyle tech brand ASTRAUX made a powerful statement at the 2025 IFA Berlin,…

2 months ago

Q&A WITH FX DEMAISON, GENESIS MAGMA RACING TECHNICAL DIRECTOR AND JUSTIN TAYLOR, GENESIS MAGMA RACING CHIEF ENGINEER

Genesis Magma Racing’s technical leads reflect on the busy first weeks of the GMR-001 Hypercar’s on-track development phase FX Demaison and…

2 months ago

OSE Immunotherapeutics Provides Update on Ongoing Proceedings Ahead of Shareholders Annual General Meeting of September 30, 2025

OSE Immunotherapeutics Provides Update on Ongoing Proceedings Ahead of Shareholders’ Annual General Meeting of September 30, 2025 NANTES, France, September…

2 months ago

Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder

Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi companyKER-0193, a novel, orally bioavailable…

2 months ago

DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq

Châtillon, France, September 5, 2025 DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN:…

2 months ago

CHARLES FUSTER ANNOUNCED AS BRAND DIRECTOR OF GENESIS FRANCE AND GENESIS ITALY

Following the announcement at the 24 Hours of Le Mans in June, Genesis continues to prepare for its arrival in…

2 months ago